Home
Almitas Capital reported a 4.1% stake in AN2 Therapeutics ANTX · 1,479,129 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 4.1%
- Last report
- 5.4% · filed 26/02/17
- Shares held
- 1,479,129 sh
- Class
- Common Stock
- Holder
- Almitas Capital
- Event date
- 26/03/31
- Filed
- 26/05/15
4.1% stake · below 5%
- Stake
- 4.1%
- Last report
- 5.4%
- Since last report
- −1.3pp
AN2 Therapeutics trades, last 26 weeks
What else happened in AN2 Therapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Almitas Capital's other 5% stake reports
- Almitas Capital
5% stakeDTF Tax-Free Income 2028 Term Fund
5% stakeDTF Tax-Free Income 2028 Term Fund
DTF
5.1% stake
355,089 sh
5.1% stake
Filed 05/15
- Almitas Capital
5% stakeAN2 Therapeutics
5% stakeAN2 Therapeutics
ANTX
5.4% stake
2,975,164 sh
5.4% stake
Filed 02/17
- Almitas Capital
5% stakePioneer Floating Rate Fund
5% stakePioneer Floating Rate Fund
PHD
5.7% stake
699,986 sh
5.7% stake
Filed 02/17
- Almitas Capital
5% stakePioneer Floating Rate Fund
5% stakePioneer Floating Rate Fund
PHD
5.7% stake
699,986 sh
5.7% stake
Filed 25/11/14
- Almitas Capital
5% stakeAN2 Therapeutics
5% stakeAN2 Therapeutics
ANTX
5.2% stake
1,428,323 sh
5.2% stake
Filed 25/11/14